Logo image of 1ISRG.MI

INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis

BIT:1ISRG - Borsa Italiana Milan - US46120E6023 - Common Stock - Currency: EUR

577.3  +49.6 (+9.4%)

Fundamental Rating

6

Taking everything into account, 1ISRG scores 6 out of 10 in our fundamental rating. 1ISRG was compared to 55 industry peers in the Health Care Equipment & Supplies industry. 1ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. 1ISRG shows excellent growth, but is valued quite expensive already. With these ratings, 1ISRG could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

1ISRG had positive earnings in the past year.
1ISRG had a positive operating cash flow in the past year.
Each year in the past 5 years 1ISRG has been profitable.
1ISRG had a positive operating cash flow in each of the past 5 years.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

1.2 Ratios

With an excellent Return On Assets value of 12.64%, 1ISRG belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
The Return On Equity of 1ISRG (14.39%) is better than 88.24% of its industry peers.
The Return On Invested Capital of 1ISRG (11.36%) is better than 88.24% of its industry peers.
1ISRG had an Average Return On Invested Capital over the past 3 years of 12.21%. This is above the industry average of 8.18%.
Industry RankSector Rank
ROA 12.64%
ROE 14.39%
ROIC 11.36%
ROA(3y)11.47%
ROA(5y)11.62%
ROE(3y)13.27%
ROE(5y)13.48%
ROIC(3y)12.21%
ROIC(5y)11.96%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

1ISRG has a better Profit Margin (28.51%) than 98.04% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
1ISRG's Operating Margin of 26.29% is amongst the best of the industry. 1ISRG outperforms 96.08% of its industry peers.
In the last couple of years the Operating Margin of 1ISRG has declined.
1ISRG's Gross Margin of 66.98% is fine compared to the rest of the industry. 1ISRG outperforms 70.59% of its industry peers.
In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 26.29%
PM (TTM) 28.51%
GM 66.98%
OM growth 3Y0.73%
OM growth 5Y-5.65%
PM growth 3Y1.22%
PM growth 5Y-3.58%
GM growth 3Y0.37%
GM growth 5Y-1.03%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

1ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for 1ISRG has been increased compared to 1 year ago.
The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

An Altman-Z score of 61.33 indicates that 1ISRG is not in any danger for bankruptcy at the moment.
1ISRG has a Altman-Z score of 61.33. This is amongst the best in the industry. 1ISRG outperforms 98.04% of its industry peers.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 61.33
ROIC/WACC1.23
WACC9.24%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 4.30 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG has a better Current ratio (4.30) than 88.24% of its industry peers.
A Quick Ratio of 3.42 indicates that 1ISRG has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.42, 1ISRG belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.3
Quick Ratio 3.42
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

7

3. Growth

3.1 Past

1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.84%, which is quite impressive.
The Earnings Per Share has been growing by 8.97% on average over the past years. This is quite good.
1ISRG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.83%.
The Revenue has been growing by 13.85% on average over the past years. This is quite good.
EPS 1Y (TTM)25.84%
EPS 3Y19.06%
EPS 5Y8.97%
EPS Q2Q%26.03%
Revenue 1Y (TTM)14.83%
Revenue growth 3Y17.8%
Revenue growth 5Y13.85%
Sales Q2Q%16.88%

3.2 Future

The Earnings Per Share is expected to grow by 17.27% on average over the next years. This is quite good.
1ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.47% yearly.
EPS Next Y23.02%
EPS Next 2Y18.56%
EPS Next 3Y18.09%
EPS Next 5Y17.27%
Revenue Next Year14.93%
Revenue Next 2Y15.9%
Revenue Next 3Y15.82%
Revenue Next 5Y14.47%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 89.78, the valuation of 1ISRG can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 28.64. 1ISRG is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 75.11, which means the current valuation is very expensive for 1ISRG.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than the industry average as 70.59% of the companies are valued more cheaply.
1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 24.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 89.78
Fwd PE 75.11
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

1ISRG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 64.71% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
Industry RankSector Rank
P/FCF 366.44
EV/EBITDA 81.21
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1ISRG has a very decent profitability rating, which may justify a higher PE ratio.
1ISRG's earnings are expected to grow with 18.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.9
PEG (5Y)10.01
EPS Next 2Y18.56%
EPS Next 3Y18.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1ISRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTUITIVE SURGICAL INC

BIT:1ISRG (1/20/2025, 7:00:00 PM)

577.3

+49.6 (+9.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-17 2024-10-17/amc
Earnings (Next)01-22 2025-01-22/amc
Inst Owners90.55%
Inst Owner ChangeN/A
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap205.62B
Analysts81.05
Price Target563.15 (-2.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.88%
Min EPS beat(2)10.37%
Max EPS beat(2)13.38%
EPS beat(4)4
Avg EPS beat(4)8.48%
Min EPS beat(4)4.44%
Max EPS beat(4)13.38%
EPS beat(8)7
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)3.16%
EPS beat(16)13
Avg EPS beat(16)6.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.1%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)-0.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)0.12%
Revenue beat(8)2
Avg Revenue beat(8)-0.46%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)7
Avg Revenue beat(16)1.66%
PT rev (1m)13.73%
PT rev (3m)26.39%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)5.55%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)3.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 89.78
Fwd PE 75.11
P/S 27.3
P/FCF 366.44
P/OCF 117.94
P/B 13.78
P/tB 14.12
EV/EBITDA 81.21
EPS(TTM)6.43
EY1.11%
EPS(NY)7.69
Fwd EY1.33%
FCF(TTM)1.58
FCFY0.27%
OCF(TTM)4.89
OCFY0.85%
SpS21.15
BVpS41.9
TBVpS40.89
PEG (NY)3.9
PEG (5Y)10.01
Profitability
Industry RankSector Rank
ROA 12.64%
ROE 14.39%
ROCE 12.87%
ROIC 11.36%
ROICexc 15.6%
ROICexgc 16.11%
OM 26.29%
PM (TTM) 28.51%
GM 66.98%
FCFM 7.45%
ROA(3y)11.47%
ROA(5y)11.62%
ROE(3y)13.27%
ROE(5y)13.48%
ROIC(3y)12.21%
ROIC(5y)11.96%
ROICexc(3y)19.34%
ROICexc(5y)19.83%
ROICexgc(3y)20.37%
ROICexgc(5y)21.16%
ROCE(3y)13.84%
ROCE(5y)13.55%
ROICexcg growth 3Y-1.89%
ROICexcg growth 5Y-8.22%
ROICexc growth 3Y-0.57%
ROICexc growth 5Y-7.6%
OM growth 3Y0.73%
OM growth 5Y-5.65%
PM growth 3Y1.22%
PM growth 5Y-3.58%
GM growth 3Y0.37%
GM growth 5Y-1.03%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 247.98%
Cap/Sales 15.69%
Interest Coverage 250
Cash Conversion 70.95%
Profit Quality 26.12%
Current Ratio 4.3
Quick Ratio 3.42
Altman-Z 61.33
F-Score5
WACC9.24%
ROIC/WACC1.23
Cap/Depr(3y)158.69%
Cap/Depr(5y)157.89%
Cap/Sales(3y)9.9%
Cap/Sales(5y)9.4%
Profit Quality(3y)72%
Profit Quality(5y)81.76%
High Growth Momentum
Growth
EPS 1Y (TTM)25.84%
EPS 3Y19.06%
EPS 5Y8.97%
EPS Q2Q%26.03%
EPS Next Y23.02%
EPS Next 2Y18.56%
EPS Next 3Y18.09%
EPS Next 5Y17.27%
Revenue 1Y (TTM)14.83%
Revenue growth 3Y17.8%
Revenue growth 5Y13.85%
Sales Q2Q%16.88%
Revenue Next Year14.93%
Revenue Next 2Y15.9%
Revenue Next 3Y15.82%
Revenue Next 5Y14.47%
EBIT growth 1Y21.07%
EBIT growth 3Y18.66%
EBIT growth 5Y7.42%
EBIT Next Year41.57%
EBIT Next 3Y25.01%
EBIT Next 5Y22.48%
FCF growth 1Y-45.49%
FCF growth 3Y-13.13%
FCF growth 5Y-5.26%
OCF growth 1Y12.35%
OCF growth 3Y6.9%
OCF growth 5Y9.17%